AnovaOS Network Powered Patient Registry

Part of paid clinical trials in Arlington Heights, Illinois.

Sponsor
Anova Enterprises, Inc
Study ID
NCT05013944
Status
Recruiting

Conditions

  • Certain Conditions Originating in the Perinatal Period
  • Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)
  • Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)
  • Diseases of the Circulatory System
  • Diseases of the Digestive System
  • Diseases of the Ear and Mastoid Process
  • Diseases of the Eye and Adnexa
  • Diseases of the Genitourinary System
  • Diseases of the Musculoskeletal System and Connective Tissue
  • Diseases of the Nervous System
  • Diseases of the Respiratory System
  • Diseases of the Skin and Subcutaneous Tissue
  • Endocrine, Nutritional and Metabolic Diseases (E00-E89)
  • External Causes of Morbidity and Mortality
  • Factors Influencing Health Status and Contact With Health Services
  • Infectious Disease
  • Injury, Poisoning and Certain Other Consequences of External Causes
  • Mental and Behavioural Disorders
  • Neoplasms
  • Pregnancy, Childbirth and the Puerperium
  • Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

Key Dates

Start date
Sep 1, 2021
Status verified
Jan 2024
Primary completion
Aug 31, 2025
Completion
Aug 31, 2026

Study Design

Enrollment
100,000 participants (estimated)

Primary Outcome Measure

Assess Natural history [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Anova Enterprises, Inc.Arlington HeightsIllinois60005
Martin Walsh
224-218-2408
Christopher Beardmore (PRINCIPAL_INVESTIGATOR)

Find similar trials in Arlington Heights, IL

Related Studies